APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anticoagulant Reversal Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anticoagulant Reversal Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025196 pages

Choose your research edition.

Industry ResearchAnticoagulant Reversal Agent Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Anticoagulant Reversal Agent Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Anticoagulant Reversal Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anticoagulant Reversal Agent Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Anticoagulant Reversal Agent Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anticoagulant Reversal Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Anticoagulant Reversal Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anticoagulant Reversal Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anticoagulant Reversal Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anticoagulant Reversal Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anticoagulant Reversal Agent include DSM, AdvaCare, Bayer AG, Brilliant Pharmaceutical, Bristol-Myers Squibb Company, Cambryn Biologics, eXithera Pharmaceuticals, Innopharma and Ionis Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Anticoagulant Reversal Agent market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anticoagulant Reversal Agent and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anticoagulant Reversal Agent revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Anticoagulant Reversal Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Anticoagulant Reversal Agent Segment by Company

DSM

AdvaCare

Bayer AG

Brilliant Pharmaceutical

Bristol-Myers Squibb Company

Cambryn Biologics

eXithera Pharmaceuticals

Innopharma

Ionis Pharmaceuticals

Shandong Guangtongbao Pharmaceuticals

Suicheng Pharmaceutical

Wuhu Kangqi Pharmaceuticals

Cheng Yi Pharmaceutical

Jiangsu Huayang Pharmaceutical

Anticoagulant Reversal Agent Segment by Type

Injection Fluid

Tablet

Others

Anticoagulant Reversal Agent Segment by Application

Hospital

Research Institute

Others

Anticoagulant Reversal Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticoagulant Reversal Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anticoagulant Reversal Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticoagulant Reversal Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anticoagulant Reversal Agent in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anticoagulant Reversal Agent industry.

Chapter 3: Detailed analysis of Anticoagulant Reversal Agent companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anticoagulant Reversal Agentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anticoagulant Reversal Agent Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Injection Fluid Table 3. Key Players of Tablet Table 4. Key Players of Others Table 4. Global Anticoagulant Reversal Agent Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Research Institute Table 7. Key Players of Others Table 8. Global Anticoagulant Reversal Agent Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Anticoagulant Reversal Agent Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Anticoagulant Reversal Agent Market Share by Region (2021-2026) Table 11. Global Anticoagulant Reversal Agent Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Anticoagulant Reversal Agent Market Share by Region (2027-2032) Table 13. Anticoagulant Reversal Agent Industry Trends Table 14. Anticoagulant Reversal Agent Industry Drivers Table 15. Anticoagulant Reversal Agent Industry Opportunities and Challenges Table 16. Anticoagulant Reversal Agent Industry Restraints Table 17. Global Anticoagulant Reversal Agent Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Anticoagulant Reversal Agent Revenue Market Share by Company (2021-2026) Table 19. Global Anticoagulant Reversal Agent Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Anticoagulant Reversal Agent Key Company Head Office and Area Served Table 21. Global Anticoagulant Reversal Agent Company, Product Type & Application Table 22. Global Anticoagulant Reversal Agent Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Anticoagulant Reversal Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Anticoagulant Reversal Agent Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Anticoagulant Reversal Agent Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Anticoagulant Reversal Agent Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2021-2026) Table 29. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2027-2032) Table 30. Global Anticoagulant Reversal Agent Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Anticoagulant Reversal Agent Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Anticoagulant Reversal Agent Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2021-2026) Table 34. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2027-2032) Table 35. DSM Company Information Table 36. DSM Business Overview Table 37. DSM Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. DSM Anticoagulant Reversal Agent Product Portfolio Table 39. DSM Recent Development Table 40. AdvaCare Company Information Table 41. AdvaCare Business Overview Table 42. AdvaCare Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. AdvaCare Anticoagulant Reversal Agent Product Portfolio Table 44. AdvaCare Recent Development Table 45. Bayer AG Company Information Table 46. Bayer AG Business Overview Table 47. Bayer AG Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bayer AG Anticoagulant Reversal Agent Product Portfolio Table 49. Bayer AG Recent Development Table 50. Brilliant Pharmaceutical Company Information Table 51. Brilliant Pharmaceutical Business Overview Table 52. Brilliant Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Brilliant Pharmaceutical Anticoagulant Reversal Agent Product Portfolio Table 54. Brilliant Pharmaceutical Recent Development Table 55. Bristol-Myers Squibb Company Company Information Table 56. Bristol-Myers Squibb Company Business Overview Table 57. Bristol-Myers Squibb Company Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bristol-Myers Squibb Company Anticoagulant Reversal Agent Product Portfolio Table 59. Bristol-Myers Squibb Company Recent Development Table 60. Cambryn Biologics Company Information Table 61. Cambryn Biologics Business Overview Table 62. Cambryn Biologics Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Cambryn Biologics Anticoagulant Reversal Agent Product Portfolio Table 64. Cambryn Biologics Recent Development Table 65. eXithera Pharmaceuticals Company Information Table 66. eXithera Pharmaceuticals Business Overview Table 67. eXithera Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. eXithera Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio Table 69. eXithera Pharmaceuticals Recent Development Table 70. Innopharma Company Information Table 71. Innopharma Business Overview Table 72. Innopharma Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Innopharma Anticoagulant Reversal Agent Product Portfolio Table 74. Innopharma Recent Development Table 75. Ionis Pharmaceuticals Company Information Table 76. Ionis Pharmaceuticals Business Overview Table 77. Ionis Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Ionis Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio Table 79. Ionis Pharmaceuticals Recent Development Table 80. Shandong Guangtongbao Pharmaceuticals Company Information Table 81. Shandong Guangtongbao Pharmaceuticals Business Overview Table 82. Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio Table 84. Shandong Guangtongbao Pharmaceuticals Recent Development Table 85. Suicheng Pharmaceutical Company Information Table 86. Suicheng Pharmaceutical Business Overview Table 87. Suicheng Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Suicheng Pharmaceutical Anticoagulant Reversal Agent Product Portfolio Table 89. Suicheng Pharmaceutical Recent Development Table 90. Wuhu Kangqi Pharmaceuticals Company Information Table 91. Wuhu Kangqi Pharmaceuticals Business Overview Table 92. Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio Table 94. Wuhu Kangqi Pharmaceuticals Recent Development Table 95. Cheng Yi Pharmaceutical Company Information Table 96. Cheng Yi Pharmaceutical Business Overview Table 97. Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Product Portfolio Table 99. Cheng Yi Pharmaceutical Recent Development Table 100. Jiangsu Huayang Pharmaceutical Company Information Table 101. Jiangsu Huayang Pharmaceutical Business Overview Table 102. Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Product Portfolio Table 104. Jiangsu Huayang Pharmaceutical Recent Development Table 105. North America Anticoagulant Reversal Agent Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Anticoagulant Reversal Agent Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Anticoagulant Reversal Agent Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Anticoagulant Reversal Agent Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Anticoagulant Reversal Agent Market Size by Country (2021-2026) Table 111. North America Anticoagulant Reversal Agent Market Size by Country (2027-2032) Table 112. Europe Anticoagulant Reversal Agent Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Anticoagulant Reversal Agent Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Anticoagulant Reversal Agent Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Anticoagulant Reversal Agent Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Anticoagulant Reversal Agent Market Size by Country (2021-2026) Table 118. Europe Anticoagulant Reversal Agent Market Size by Country (2027-2032) Table 119. China Anticoagulant Reversal Agent Market Size by Type (2021-2026) & (US$ Million) Table 120. China Anticoagulant Reversal Agent Market Size by Type (2027-2032) & (US$ Million) Table 121. China Anticoagulant Reversal Agent Market Size by Application (2021-2026) & (US$ Million) Table 122. China Anticoagulant Reversal Agent Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Anticoagulant Reversal Agent Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Anticoagulant Reversal Agent Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Anticoagulant Reversal Agent Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Anticoagulant Reversal Agent Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Anticoagulant Reversal Agent Market Size by Country (2021-2026) Table 129. Asia Anticoagulant Reversal Agent Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Anticoagulant Reversal Agent Product Image Figure 2. Global Anticoagulant Reversal Agent Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Anticoagulant Reversal Agent Market Share by Type: 2025 VS 2032 Figure 4. Injection Fluid Image Figure 5. Tablet Image Figure 6. Others Image Figure 7. Global Anticoagulant Reversal Agent Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Anticoagulant Reversal Agent Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Research Institute Image Figure 11. Others Image Figure 12. Global Anticoagulant Reversal Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 14. Global Anticoagulant Reversal Agent Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Anticoagulant Reversal Agent Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Anticoagulant Reversal Agent Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Anticoagulant Reversal Agent Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2021-2032) Figure 21. Global Anticoagulant Reversal Agent Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2021-2032) Figure 23. North America Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 24. North America Anticoagulant Reversal Agent Market Share by Type (2021-2032) Figure 25. North America Anticoagulant Reversal Agent Market Share by Application (2021-2032) Figure 26. North America Anticoagulant Reversal Agent Market Share by Country (2021-2032) Figure 27. United States Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 28. Canada Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 30. Europe Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 31. Europe Anticoagulant Reversal Agent Market Share by Type (2021-2032) Figure 32. Europe Anticoagulant Reversal Agent Market Share by Application (2021-2032) Figure 33. Europe Anticoagulant Reversal Agent Market Share by Country (2021-2032) Figure 34. Germany Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 35. France Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 37. Italy Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 38. Russia Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 40. China Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 41. China Anticoagulant Reversal Agent Market Share by Type (2021-2032) Figure 42. China Anticoagulant Reversal Agent Market Share by Application (2021-2032) Figure 43. Asia Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 44. Asia Anticoagulant Reversal Agent Market Share by Type (2021-2032) Figure 45. Asia Anticoagulant Reversal Agent Market Share by Application (2021-2032) Figure 46. Asia Anticoagulant Reversal Agent Market Share by Country (2021-2032) Figure 47. Japan Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 51. India Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 52. Australia Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Anticoagulant Reversal Agent Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Anticoagulant Reversal Agent Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Anticoagulant Reversal Agent Market Share by Country (2021-2032) Figure 57. Brazil Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 62. UAE Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 64. Chile Anticoagulant Reversal Agent Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Fluid
  • Tablet
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • DSM
  • AdvaCare
  • Bayer AG
  • Brilliant Pharmaceutical
  • Bristol-Myers Squibb Company
  • Cambryn Biologics
  • eXithera Pharmaceuticals
  • Innopharma
  • Ionis Pharmaceuticals
  • Shandong Guangtongbao Pharmaceuticals
  • Suicheng Pharmaceutical
  • Wuhu Kangqi Pharmaceuticals
  • Cheng Yi Pharmaceutical
  • Jiangsu Huayang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Anticoagulant Reversal Agent Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Injection Fluid
  5. 1.2.3 Tablet
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Anticoagulant Reversal Agent Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Research Institute
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Anticoagulant Reversal Agent Growth Trends by Region
  14. 1.5.1 Global Anticoagulant Reversal Agent Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Anticoagulant Reversal Agent Market Size by Region (2021-2026)
  16. 1.5.3 Anticoagulant Reversal Agent Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Anticoagulant Reversal Agent Market Dynamics
  1. 2.1 Anticoagulant Reversal Agent Industry Trends
  2. 2.2 Anticoagulant Reversal Agent Industry Drivers
  3. 2.3 Anticoagulant Reversal Agent Industry Opportunities and Challenges
  4. 2.4 Anticoagulant Reversal Agent Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Anticoagulant Reversal Agent Revenue by Company (2021-2026)
  2. 3.2 Global Anticoagulant Reversal Agent Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Anticoagulant Reversal Agent Key Company Head office and Area Served
  4. 3.4 Global Anticoagulant Reversal Agent Company, Product Type & Application
  5. 3.5 Global Anticoagulant Reversal Agent Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Anticoagulant Reversal Agent Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Anticoagulant Reversal Agent Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Anticoagulant Reversal Agent Tier 1, Tier 2, and Tier 3
4 Anticoagulant Reversal Agent Market by Type
  1. 4.1 Global Anticoagulant Reversal Agent Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Anticoagulant Reversal Agent Market Size by Type (2021-2032)
  3. 4.3 Global Anticoagulant Reversal Agent Market Size Share by Type (2021-2032)
5 Anticoagulant Reversal Agent Market by Application
  1. 5.1 Global Anticoagulant Reversal Agent Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Anticoagulant Reversal Agent Market Size by Application (2021-2032)
  3. 5.3 Global Anticoagulant Reversal Agent Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 DSM
  2. 6.1.1 DSM Company Information
  3. 6.1.2 DSM Business Overview
  4. 6.1.3 DSM Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 DSM Anticoagulant Reversal Agent Product Portfolio
  6. 6.1.5 DSM Recent Developments
  7. 6.2 AdvaCare
  8. 6.2.1 AdvaCare Company Information
  9. 6.2.2 AdvaCare Business Overview
  10. 6.2.3 AdvaCare Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 AdvaCare Anticoagulant Reversal Agent Product Portfolio
  12. 6.2.5 AdvaCare Recent Developments
  13. 6.3 Bayer AG
  14. 6.3.1 Bayer AG Company Information
  15. 6.3.2 Bayer AG Business Overview
  16. 6.3.3 Bayer AG Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer AG Anticoagulant Reversal Agent Product Portfolio
  18. 6.3.5 Bayer AG Recent Developments
  19. 6.4 Brilliant Pharmaceutical
  20. 6.4.1 Brilliant Pharmaceutical Company Information
  21. 6.4.2 Brilliant Pharmaceutical Business Overview
  22. 6.4.3 Brilliant Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Brilliant Pharmaceutical Anticoagulant Reversal Agent Product Portfolio
  24. 6.4.5 Brilliant Pharmaceutical Recent Developments
  25. 6.5 Bristol-Myers Squibb Company
  26. 6.5.1 Bristol-Myers Squibb Company Company Information
  27. 6.5.2 Bristol-Myers Squibb Company Business Overview
  28. 6.5.3 Bristol-Myers Squibb Company Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bristol-Myers Squibb Company Anticoagulant Reversal Agent Product Portfolio
  30. 6.5.5 Bristol-Myers Squibb Company Recent Developments
  31. 6.6 Cambryn Biologics
  32. 6.6.1 Cambryn Biologics Company Information
  33. 6.6.2 Cambryn Biologics Business Overview
  34. 6.6.3 Cambryn Biologics Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cambryn Biologics Anticoagulant Reversal Agent Product Portfolio
  36. 6.6.5 Cambryn Biologics Recent Developments
  37. 6.7 eXithera Pharmaceuticals
  38. 6.7.1 eXithera Pharmaceuticals Company Information
  39. 6.7.2 eXithera Pharmaceuticals Business Overview
  40. 6.7.3 eXithera Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 eXithera Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio
  42. 6.7.5 eXithera Pharmaceuticals Recent Developments
  43. 6.8 Innopharma
  44. 6.8.1 Innopharma Company Information
  45. 6.8.2 Innopharma Business Overview
  46. 6.8.3 Innopharma Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Innopharma Anticoagulant Reversal Agent Product Portfolio
  48. 6.8.5 Innopharma Recent Developments
  49. 6.9 Ionis Pharmaceuticals
  50. 6.9.1 Ionis Pharmaceuticals Company Information
  51. 6.9.2 Ionis Pharmaceuticals Business Overview
  52. 6.9.3 Ionis Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Ionis Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio
  54. 6.9.5 Ionis Pharmaceuticals Recent Developments
  55. 6.10 Shandong Guangtongbao Pharmaceuticals
  56. 6.10.1 Shandong Guangtongbao Pharmaceuticals Company Information
  57. 6.10.2 Shandong Guangtongbao Pharmaceuticals Business Overview
  58. 6.10.3 Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio
  60. 6.10.5 Shandong Guangtongbao Pharmaceuticals Recent Developments
  61. 6.11 Suicheng Pharmaceutical
  62. 6.11.1 Suicheng Pharmaceutical Company Information
  63. 6.11.2 Suicheng Pharmaceutical Business Overview
  64. 6.11.3 Suicheng Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Suicheng Pharmaceutical Anticoagulant Reversal Agent Product Portfolio
  66. 6.11.5 Suicheng Pharmaceutical Recent Developments
  67. 6.12 Wuhu Kangqi Pharmaceuticals
  68. 6.12.1 Wuhu Kangqi Pharmaceuticals Company Information
  69. 6.12.2 Wuhu Kangqi Pharmaceuticals Business Overview
  70. 6.12.3 Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Product Portfolio
  72. 6.12.5 Wuhu Kangqi Pharmaceuticals Recent Developments
  73. 6.13 Cheng Yi Pharmaceutical
  74. 6.13.1 Cheng Yi Pharmaceutical Company Information
  75. 6.13.2 Cheng Yi Pharmaceutical Business Overview
  76. 6.13.3 Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Product Portfolio
  78. 6.13.5 Cheng Yi Pharmaceutical Recent Developments
  79. 6.14 Jiangsu Huayang Pharmaceutical
  80. 6.14.1 Jiangsu Huayang Pharmaceutical Company Information
  81. 6.14.2 Jiangsu Huayang Pharmaceutical Business Overview
  82. 6.14.3 Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Product Portfolio
  84. 6.14.5 Jiangsu Huayang Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Anticoagulant Reversal Agent Market Size (2021-2032)
  2. 7.2 North America Anticoagulant Reversal Agent Market Size by Type
  3. 7.2.1 North America Anticoagulant Reversal Agent Market Size by Type (2021-2026)
  4. 7.2.2 North America Anticoagulant Reversal Agent Market Size by Type (2027-2032)
  5. 7.2.3 North America Anticoagulant Reversal Agent Market Share by Type (2021-2032)
  6. 7.3 North America Anticoagulant Reversal Agent Market Size by Application
  7. 7.3.1 North America Anticoagulant Reversal Agent Market Size by Application (2021-2026)
  8. 7.3.2 North America Anticoagulant Reversal Agent Market Size by Application (2027-2032)
  9. 7.3.3 North America Anticoagulant Reversal Agent Market Share by Application (2021-2032)
  10. 7.4 North America Anticoagulant Reversal Agent Market Size by Country
  11. 7.4.1 North America Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Anticoagulant Reversal Agent Market Size by Country (2021-2026)
  13. 7.4.3 North America Anticoagulant Reversal Agent Market Size by Country (2027-2032)
  14. 7.4.4 North America Anticoagulant Reversal Agent Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Anticoagulant Reversal Agent Market Size (2021-2032)
  2. 8.2 Europe Anticoagulant Reversal Agent Market Size by Type
  3. 8.2.1 Europe Anticoagulant Reversal Agent Market Size by Type (2021-2026)
  4. 8.2.2 Europe Anticoagulant Reversal Agent Market Size by Type (2027-2032)
  5. 8.2.3 Europe Anticoagulant Reversal Agent Market Share by Type (2021-2032)
  6. 8.3 Europe Anticoagulant Reversal Agent Market Size by Application
  7. 8.3.1 Europe Anticoagulant Reversal Agent Market Size by Application (2021-2026)
  8. 8.3.2 Europe Anticoagulant Reversal Agent Market Size by Application (2027-2032)
  9. 8.3.3 Europe Anticoagulant Reversal Agent Market Share by Application (2021-2032)
  10. 8.4 Europe Anticoagulant Reversal Agent Market Size by Country
  11. 8.4.1 Europe Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Anticoagulant Reversal Agent Market Size by Country (2021-2026)
  13. 8.4.3 Europe Anticoagulant Reversal Agent Market Size by Country (2027-2032)
  14. 8.4.4 Europe Anticoagulant Reversal Agent Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Anticoagulant Reversal Agent Market Size (2021-2032)
  2. 9.2 China Anticoagulant Reversal Agent Market Size by Type
  3. 9.2.1 China Anticoagulant Reversal Agent Market Size by Type (2021-2026)
  4. 9.2.2 China Anticoagulant Reversal Agent Market Size by Type (2027-2032)
  5. 9.2.3 China Anticoagulant Reversal Agent Market Share by Type (2021-2032)
  6. 9.3 China Anticoagulant Reversal Agent Market Size by Application
  7. 9.3.1 China Anticoagulant Reversal Agent Market Size by Application (2021-2026)
  8. 9.3.2 China Anticoagulant Reversal Agent Market Size by Application (2027-2032)
  9. 9.3.3 China Anticoagulant Reversal Agent Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Anticoagulant Reversal Agent Market Size (2021-2032)
  2. 10.2 Asia Anticoagulant Reversal Agent Market Size by Type
  3. 10.2.1 Asia Anticoagulant Reversal Agent Market Size by Type (2021-2026)
  4. 10.2.2 Asia Anticoagulant Reversal Agent Market Size by Type (2027-2032)
  5. 10.2.3 Asia Anticoagulant Reversal Agent Market Share by Type (2021-2032)
  6. 10.3 Asia Anticoagulant Reversal Agent Market Size by Application
  7. 10.3.1 Asia Anticoagulant Reversal Agent Market Size by Application (2021-2026)
  8. 10.3.2 Asia Anticoagulant Reversal Agent Market Size by Application (2027-2032)
  9. 10.3.3 Asia Anticoagulant Reversal Agent Market Share by Application (2021-2032)
  10. 10.4 Asia Anticoagulant Reversal Agent Market Size by Country
  11. 10.4.1 Asia Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Anticoagulant Reversal Agent Market Size by Country (2021-2026)
  13. 10.4.3 Asia Anticoagulant Reversal Agent Market Size by Country (2027-2032)
  14. 10.4.4 Asia Anticoagulant Reversal Agent Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Anticoagulant Reversal Agent Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Anticoagulant Reversal Agent Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Anticoagulant Reversal Agent Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst